Baijin Life Science Holdings Limited (1466.HK) HKSE

0.51

+0.01(+2.00%)

Updated at December 05 03:50PM

Currency In HKD

Valuation

Market Cap468.68M
Enterprise Value520.84M
P/E Ratio-1,096.26
PEG Ratio22.51
Price/Sales Ratio2.91
Price/Book Ratio2.49
Enterprise/Revenue3.29
Enterprise/EBITDA71.3

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0
Operating Margin-0.01

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue135.56M
Revenue/Share0.2
Gross Profit41.99M
EBITDA6.26M
Net Income-316,000
Diluted EPS-0

Balance Sheet

Total Cash47.77M
Total Cash/Share0.07
Total Debt99.93M
Total Debt/Equity0.72
Current Ratio4.57
Book Value Per Share0.23

Price History

52-Week Change-16.39
52-Week High0.76
52-Week Low0.4
Moving Average 50 Days0.56
Moving Average 200 Days0.62

Statistics

Average Volume378,792
Shares Outstanding773.37M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor61:58
Last Split DateApril 06, 2022